nicole junkermann tania boler

Empowering Women’s Health: Exploring Femtech Innovations by Nicole Junkermann and Tania Boler

The Femtech industry, poised to reach a staggering $50 billion valuation by 2025, is causing a global transformation in women’s health. Driving this revolution are female entrepreneurs who are increasingly making their mark, attracting more women into the venture capital arena. Among these trailblazers is Nicole Junkermann and Tania Boler. Nicole Junkermann is an international investor, entrepreneur, and principal of the venture capital fund NJF Capital. She emphasises the importance of sustained investor support for this burgeoning market, which addresses the health needs of more than half the world’s population.

nicole junkermann tania boler, femtech,

Nicole Junkermann’s investment in Elvie, a pioneering Femtech company, underscores her commitment to driving innovation in the sector. Elvie, led by Co-founder and CEO Tania Boler, is on a mission to enhance women’s lives through intelligent technology, offering innovative solutions to address various women’s health issues. Notable among Elvie’s products is the award-winning Elvie Trainer, designed to strengthen the pelvic floor for faster postnatal recovery. Another groundbreaking product is the Elvie Pump, touted as the world’s first silent wearable breast pump. Nicole Junkermann lauds these products as transformative, stating that they redefine healthcare by empowering women with control and autonomy over their bodies.

nicole junkermann tania boler, femtech,
Photo by Matthias Zomer on

Recognising the significance of Femtech’s role in societal progress, Nicole Junkermann stresses the need for continued investment. Elvie, as a testament to this potential, has successfully secured over $53 million in funding to date, with support from IPGL, Impact Ventures, and recently, HSBC. Beyond being a source of future growth, Femtech reflects a broader shift towards a fairer society, according to Nicole Junkermann.

Femtech is not only a lucrative investment but also a crucial driver in improving women’s health. It addresses the stark gender imbalance in venture capital funding, where only 1% goes to female-led UK start-ups. Nicole Junkermann anticipates witnessing further innovation in Femtech as the industry expands, contributing to advancements in women’s health on a global scale